𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Anti-HER2 vaccines: new prospects for breast cancer therapy

✍ Scribed by Maha Zohra Ladjemi; William Jacot; Thierry Chardès; André Pèlegrin; Isabelle Navarro-Teulon

Publisher
Springer-Verlag
Year
2010
Tongue
English
Weight
283 KB
Volume
59
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bispecific monoclonal antibody therapy (
Bispecific monoclonal antibody therapy (anti HER-2/neu × anti CD 64) for human breast cancers that overexpress HER-2/neu
✍ Frank H. Valone; Peter A. Kaufman; Michael W. Fanger; Paul M. Guyre; Clark Sprin 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB

One of the most critical issues regarding management of early breast cancer is the proper detection and correct estimation of its malignant potential. In recent years, primarily through mammography, the frequency of ductal carcinoma in situ (DCIS) in malignant breast biopsies has increased several f

New systemic therapy for breast cancer
New systemic therapy for breast cancer
✍ Pierre Fumoleau; Dominique Berton-Rigaud; Valerie Delecroix; Franck Priou; Steph 📂 Article 📅 1999 🏛 Springer Japan 🌐 English ⚖ 365 KB
Combined antiestrogen and cytotoxic ther
Combined antiestrogen and cytotoxic therapy with pseudomonas vaccine immunotherapy for metastatic breast cancer a prospective, randomized trial
✍ Gabriel N. Hortobagyi; Aman U. Buzdar; Debra Frye; Verena Hug; Giuseppe Fraschin 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 761 KB

One hundred thirty-three consecutive, previously untreated patients who had metastatic breast cancer were treated with a combination of 5-fluorouraci1, doxorubicin (Adriamycin), and cyclophosphamide (FAC). They were randomly assigned to receive nonspecific immunotherapy with a heptavalent pseudomona